Cjc 1295 Ipamorelin Reconstitution Guide

CJC-1295 and Ipamorelin are growth hormone secretagogue peptides often prescribed together as a blend. If your provider has prescribed this combination, understanding CJC-1295 Ipamorelin reconstitution is key to getting accurate doses and optimal results. This guide explains how to mix, measure, and store your CJC-1295/Ipamorelin prescription.

Key Takeaways: - Learn how cjc-1295 / ipamorelin blends work - Reconstituting Your CJC-1295 / Ipamorelin Vial - Timing and Protocol Considerations - Storage and Shelf Life

These peptides work differently than repair peptides like BPC-157. Timing, dose accuracy, and proper storage all play important roles. Let's break it down.

How CJC-1295 / Ipamorelin Blends Work

CJC-1295 is a growth hormone releasing hormone (GHRH) analog. It tells your pituitary gland to produce and release growth hormone. Ipamorelin is a growth hormone releasing peptide (GHRP) that amplifies that signal through a different receptor pathway.

When combined, they create a combined effect. The CJC-1295 provides a sustained baseline signal, while the Ipamorelin adds a pulse-like boost. Many providers prescribe them together because the combination may produce a more natural growth hormone release pattern than either peptide alone.

Most compounding pharmacies prepare CJC-1295/Ipamorelin as a pre-mixed blend in a single vial. The label will show the amount of each peptide) for example, "CJC-1295 2 mg / Ipamorelin 2 mg" in one vial. This simplifies reconstitution because you only need to mix one vial instead of two.

Some providers prescribe them in separate vials. In that case, you reconstitute each vial independently and administer them as separate injections. Never combine the contents of two different vials into one unless your pharmacy specifically prepared them that way.

"The conversation about obesity needs to shift from willpower to biology. These medications work because obesity is a neuroendocrine disease, not a character flaw.", Dr. Fatima Cody Stanford, MD, MPH, Massachusetts General Hospital

Reconstituting Your CJC-1295 / Ipamorelin Vial

The reconstitution process follows standard peptide mixing steps. The key difference is paying attention to the total content of both peptides when calculating your concentration.

For a blended vial (example: 6 mg total (3 mg CJC-1295 + 3 mg Ipamorelin):

If you add 2 mL of bacteriostatic water, your concentration is 3 mg per mL total blend. Each syringe unit contains 30 mcg of total peptide (15 mcg CJC-1295 + 15 mcg Ipamorelin, in a 50/50 blend).

Your provider will prescribe a dose based on the individual peptide amounts) for example, "300 mcg CJC-1295 / 300 mcg Ipamorelin per injection." With the above reconstitution, that equals 20 units on your syringe.

Mixing steps:

1. Wash hands thoroughly
2. Swab vial stoppers with alcohol
3. Draw your chosen volume of BAC water (commonly 2 mL for these blends)
4. Add water to the peptide vial (aim at the glass wall, not the powder
5. Swirl gently until dissolved (2-5 minutes)
6. Verify the solution is clear and colorless
7. Label with date and concentration
8. Refrigerate immediately

Use the to get your exact syringe units based on your specific vial contents and prescribed dose.

Get instant dose calculations with our free . Enter your blend amounts and water volume for precise measurements.

Timing and Protocol Considerations

CJC-1295/Ipamorelin protocols are more timing-sensitive than some other peptides. Here's what to know.

Best time to inject: Most providers recommend injecting at bedtime. Growth hormone is naturally released in pulses during deep sleep. Injecting before bed aligns with your body's natural rhythm and may enhance the growth hormone response.

Alternative timing: Some protocols call for morning injection or even twice-daily dosing. Follow your provider's specific instructions. If they prescribe twice daily, common timing is morning (fasting) and bedtime.

Fasting window: Growth hormone release can be blunted by elevated blood sugar and insulin. Many providers recommend injecting at least 2 hours after eating and waiting 30-60 minutes before eating after injection. This is especially important for the bedtime dose) avoid late-night snacking.

Protocol duration: CJC-1295/Ipamorelin protocols typically run 3-6 months. Some providers prescribe ongoing use. Others cycle on and off. Your provider will determine the right duration based on your health goals and lab work.

Tracking matters: Log each dose time in the so you and your provider can see your adherence pattern. Consistent timing leads to more consistent results.

If you're also using other peptides in your protocol, check our guide on for timing considerations.

Storage and Shelf Life

CJC-1295/Ipamorelin blends follow standard peptide storage guidelines, but the blend format has a few nuances.

Unreconstituted: Store in the refrigerator at 36-46 degrees Fahrenheit. Blended vials from compounding pharmacies are typically stable for the same duration as single-peptide vials (check your pharmacy label for the specific expiration date.

Reconstituted: Refrigerate immediately after mixing. Use within 28 days. The 28-day window applies from the moment you add bacteriostatic water, regardless of how many doses remain.

Temperature sensitivity: CJC-1295 can be somewhat more temperature-sensitive than simpler peptides. Minimize the time your reconstituted vial spends at room temperature. Take it out, draw your dose, and put it back. Don't leave it on the nightstand while you get ready for bed.

Dose tracking: With blended vials, it's especially important to track doses accurately. You need to know how much of each peptide you have left. The calculates remaining vial contents automatically based on your logged doses.

Travel: Keep reconstituted CJC-1295/Ipamorelin cold during travel with an insulated bag and gel ice packs. For trips longer than a few days, bring unreconstituted vials and BAC water separately.

Frequently Asked Questions

What's the difference between CJC-1295 with DAC and without DAC?

DAC (Drug Affinity Complex) is a modification that extends the half-life of CJC-1295 from about 30 minutes to several days. CJC-1295 without DAC (also called Modified GRF 1-29) requires more frequent dosing but produces more natural, pulsatile growth hormone release. Most providers now prefer CJC-1295 without DAC for this reason. Your pharmacy label will specify which version you have.

Can I take CJC-1295/Ipamorelin with food in my stomach?

Technically yes, but elevated insulin from a recent meal may reduce the growth hormone response. For best results, most providers recommend a 2-hour fasting window before injection. If you must eat close to injection time, choose a low-carb, high-protein option to minimize insulin impact.

How long until I notice results from CJC-1295/Ipamorelin?

Results vary by individual and health goals. Some people notice improved sleep quality within the first 1-2 weeks. Changes in body composition, recovery, and energy typically develop over 4-12 weeks. Your provider will monitor your progress with lab work and clinical assessments.

Do I need blood work before starting CJC-1295/Ipamorelin?

Most providers require baseline lab work including IGF-1 levels before prescribing growth hormone secretagogues. They'll also order follow-up labs to monitor your response and ensure safety. This is standard practice and an important part of responsible prescribing.

Can I stack CJC-1295/Ipamorelin with BPC-157 or TB-500?

Some providers prescribe multiple peptides simultaneously for different clinical goals) for example, CJC-1295/Ipamorelin for growth hormone support alongside BPC-157 for tissue repair. If your provider recommends this approach, they'll give you specific timing and dosing instructions for each peptide. Use separate injection sites for each one.

What's Your Next Move?

You have the information. Now let a licensed provider help you put it into action. FormBlends makes it simple, answer a few questions and get a personalized recommendation.

---

Sources & References

1. Sikiric P, Hahm KB, Blagaic AB, et al. Stable Gastric Pentadecapeptide BPC 157, Robert's Cytoprotection, Adaptive Cytoprotection, and Therapeutic Effects. Curr Pharm Des. 2018;24(18):1990-2001. Doi:10.2174/1381612824666180515125918
2. Chang CH, Tsai WC, Lin MS, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol. 2011;110(3):774-780. Doi:10.1152/japplphysiol.00945.2010
3. Seiwerth S, Brcic L, Vuletic LB, et al. BPC 157 and blood vessels. Curr Pharm Des. 2014;20(7):1121-1125. Doi:10.2174/13816128113199990421
4. Bock-Marquette I, Saxena A, White MD, et al. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature. 2004;432(7016):466-472. Doi:10.1038/nature03000
5. Malinda KM, Sidhu GS, Mani H, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364-368. Doi:10.1046/j.1523-1747.1999.00708.x
6. Ionescu M, Frohman LA. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J Clin Endocrinol Metab. 2006;91(12):4792-4797. Doi:10.1210/jc.2006-1702

This content is provided for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed healthcare provider with any questions about a medical condition or treatment plan.

Last updated: 2026-03-24